Global landscape and trends in lifetime risks of haematologic malignancies in 185 countries: population-based estimates from GLOBOCAN 2022Kexin Sun, Wenqiang Wei, Yi Pang et al.|EClinicalMedicine|2025Cited by 24
Lifetime probabilities of developing and dying from cancer in China: comparison with Japan and the United States in 2022Qian Zhu, Wenqiang Wei, Kexin Sun et al.|Science China Life Sciences|2025Cited by 8
Over one‐third of cancer cases and two‐fifths of cancer deaths in southern China are preventable: Insights from the latest representative population‐based cancer registry data and risk factor surveyXiaolan Wen, Shaoming Wang, Xueyan Zheng et al.|International Journal of Cancer|2025Cited by 1